Inactive Instrument

Cornerstone Therapeutics, Inc. Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

28/02/14	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
03/02/14	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
31/01/14	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
20/11/13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
31/10/13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU

16/09/13	USA-Les valeurs à suivre à Wall Street (actualisé)
16/09/13	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Jon Zwinski CEO	Chief Executive Officer	-	31/12/2020
William James Alexander CTO	Chief Tech/Sci/R&D Officer	76	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.21%	-4.52%	+19.86%	+67.25%	48.26B
OTSUKA HOLDINGS CO., LTD.	-2.49%	-4.24%	+38.37%	+110.97%	40.5B
CIPLA LIMITED	+0.72%	-1.01%	-9.49%	+11.66%	11.85B
ZYDUS LIFESCIENCES LIMITED	+3.29%	-0.38%	+14.58%	+82.76%	11.83B
KRKA, D. D.	+2.31%	0.00%	+26.67%	+146.30%	9.36B
GEDEON RICHTER	-0.47%	-2.82%	+22.93%	+38.92%	7.5B
ONO PHARMACEUTICAL CO., LTD.	-1.23%	-1.31%	+36.14%	-13.14%	7.37B
GLENMARK PHARMACEUTICALS LIMITED	+0.60%	-1.13%	+19.49%	+208.86%	7.28B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-0.16%	-2.36%	-46.14%	+18.48%	5.19B
Average	+0.26%	-2.09%	+13.60%	+74.67%	16.57B
Weighted average by Cap.	-0.34%	-1.71%	+21.21%	+80.72%